Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.755 USD | -7.14% | -13.55% | -88.08% |
May. 09 | Transcript : Amylyx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 99.3M | Sales 2025 * | - | Capitalization | 119M |
---|---|---|---|---|---|
Net income 2024 * | -171M | Net income 2025 * | -75M | EV / Sales 2024 * | 0.32 x |
Net cash position 2024 * | 87.38M | Net cash position 2025 * | 62.5M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.7
x | P/E ratio 2025 * |
-1.64
x | Employees | 384 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.02% |
Latest transcript on Amylyx Pharmaceuticals, Inc.
1 day | -7.14% | ||
1 week | -13.55% | ||
Current month | -3.04% | ||
1 month | -16.43% | ||
3 months | -89.20% | ||
6 months | -85.94% | ||
Current year | -88.08% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Klee
FOU | Founder | 34 | 12-12-31 |
Josh Cohen
FOU | Founder | 33 | 12-12-31 |
Jim Frates
DFI | Director of Finance/CFO | 56 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Milne
CHM | Chairman | 80 | 14-12-31 |
Kari Firestone
BRD | Director/Board Member | - | 23-03-15 |
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 21-03-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | +2.72% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 0 M€ | +9.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.755 | -7.14% | 1,590,296 |
24-05-09 | 1.89 | -2.07% | 3,284,794 |
24-05-08 | 1.93 | -2.03% | 1,514,637 |
24-05-07 | 1.97 | -1.01% | 900,905 |
24-05-06 | 1.99 | -1.97% | 1,527,305 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.08% | 119M | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- AMLX Stock